Thus, the aim of the present study was to characterize a broad spectrum of a large number of different melanoma-associated epitope (MAE)-specific CD8+ T cell populations and their dynamics in the peripheral blood of anti-PD-1-treated patients to screen for further TAAs with potential clinical relevance. Here, PDCD1 is linked to melanoma.